KIMS schedules analyst meeting in Mumbai on August 14
Krishna Institute of Medical Sciences Limited has scheduled an Analyst and Institutional Investor Meeting on August 14, 2026, in Mumbai, as part of the Equirus Annual India Conference. The meeting will be conducted as a Group Meeting to discuss operations and strategy. The company confirmed that no unpublished price sensitive information will be shared.

*this image is generated using AI for illustrative purposes only.
Krishna Institute of Medical Sciences Limited has scheduled an Analyst and Institutional Investor Meeting on August 14, 2026, in Mumbai. The meeting is part of the Equirus Annual India Conference and will be conducted as a Group Meeting. This engagement provides a platform for the company to interact with analysts and institutional investors regarding its operations and strategy.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that no unpublished price sensitive information would be shared during the proceedings. The schedule remains subject to change due to exigencies.
Meeting Details
The following table outlines the specifics of the scheduled interaction:
| Date of Meeting | Event | Venue | Type of Meeting |
|---|---|---|---|
| August 14, 2026 | Equirus Annual India Conference | Mumbai, India | Group Meeting |
Nagajayanthi J.R, Company Secretary & Compliance Officer, signed the disclosure on June 5, 2026. The intimation was submitted to both the Bombay Stock Exchange Ltd (BSE) and the National Stock Exchange (NSE) for their information and records.
Historical Stock Returns for Krishna Institute of Medical Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.14% | +0.57% | +15.48% | +11.66% | +18.02% | +295.68% |
What strategic initiatives or growth plans is KIMS likely to highlight during the meeting?
How might the engagement with institutional investors influence KIMS' stock performance in the short term?
What are the potential market reactions if KIMS hints at expansion or new partnerships during the conference?


































